In Vitro Diagnostic (IVD) Reagents Market Worth $77.6 Billion by 2027


Posted December 28, 2022 by ameymeti

In Vitro Diagnostic (IVD) Reagents Market Worth $77.6 Billion by 2027

 
In Vitro Diagnostic (IVD) Reagents Market Worth $77.6 Billion by 2027
According to this latest publication from Meticulous Researchยฎ, the IVD reagents market is expected to grow at a CAGR of 7% from 2020 to reach $77.6 billion by 2027. The high growth of the IVD reagents market is mainly attributed to the factors such as increasing global prevalence of acute and chronic infectious diseases coupled with rising geriatric population, increasing adoption of flow cytometry techniques in research and academia, increase in funding for research activities, and rising proteomics and genomics research studies. Moreover, the growing demand for protein therapeutics and personalized medicines and emerging economies offer significant growth opportunities for the players operating in this market. However, the unfavorable restrictions on approval procedure is expected to hamper the growth of the IVD reagents market to some extent.

The global IVD reagents market study presents historical market data in terms of values (2018 and 2019), estimated current data (2020), and forecasts for 2027- by type (oligonucleotide, antibodies, nucleic acid probe), technology (immunoassay, hematology, microbiology), use (research, analyte specific reagent), end user (IVD manufacturer, clinical laboratory), and geography. The study also evaluates industry competitors and analyzes the market at a country level.

Based on type, the antibodies segment is estimated to hold the largest share of the overall IVD reagents market in 2020. However, the oligonucleotides segment is expected to grow at the fastest CAGR during the forecast period. The fast growth of this segment is mainly attributed to the factors such as advancements in the field of genomics research, growing adoption of custom oligonucleotides, and rising strategic developments such as agreements and collaborations to expand oligonucleotides market.

Based on use, the research use segment is estimated to hold the largest share of the overall IVD reagents market in 2020. However, the clinical use segment is expected to grow with the fastest CAGR during the forecast period, mainly due to the factors such as rising adoption of advanced diagnostic modalities, growing importance of early disease diagnosis, number of diagnostic product launches, and demand for innovative reagents and assays for clinical usage.

Based on end user, the IVD manufacturers segment is estimated to command the largest share of the overall IVD reagents market in 2020. The factors such as rising number of research activities for the development of innovative IVDs, growing public and private funds, and rising demand for advanced disease diagnostics are expected to drive the growth of the IVD reagents market for IVD manufacturing during the forecast period. Moreover, the recent outbreak of COVID-19 is also expected to support the growth of the IVD reagents market for this segment. However, the clinical laboratories segment is expected to register the highest growth during the forecast period.

Geographic Review:

This research report analyzes major geographies and provides comprehensive analysis for North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is estimated to dominate the global IVD reagents market in 2020, followed by Europe and Asia Pacific. The factors such as growing healthcare sector, increasing need to treat various infectious diseases in early stage, increasing healthcare expenditure, and growing investments in personalized medicine and development of novel advanced technologies for diagnosis are supporting the largest share of North America in the global IVD reagents market.
๐‘บ๐’‘๐’†๐’‚๐’Œ ๐’•๐’ ๐‘จ๐’๐’‚๐’๐’š๐’”๐’•:https://www.meticulousresearch.com/speak-to-analyst/cp_id=5110?utm_source=prodyuct&utm_medium=Social&utm_campaign=Product&utm_content=15-12-2022
Key Players

The report includes competitive landscape based on the extensive assessment of the product portfolio offerings, geographic presence, and key strategic developments adopted by the leading market players in the industry over the past 4 years (2017-2020). The key players profiled in the global IVD reagents market are Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), LGC Biosearch Technologies (U.K.), BioLegend, Inc. (U.S.), InBios International, Inc. (U.S.), LakePharma, Inc. (U.S.), Bioline (U.K.), Abcam plc (U.K.), The Binding Site Group Ltd.(U.K.), SDIX, LLC (U.S.), DIACLONE SAS (France), Bio-Techne Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Hologic Inc. (U.S.), Bio-Synthesis Inc. (U.S.), RayBiotech, Inc. (U.S.), and Sino Biological Inc. (China).

Scope of the Report:

IVD Reagents Market, by Technology

Immunoassay/Immunochemistry
Enzyme-Linked Immunosorbent Assays (Elisa)
Western Blotting
Immunofluorescence
Immunohistochemistry
Functional Assays
Immunoprecipitation
Other Technologies
Biochemistry/Clinical Chemistry
Molecular Diagnostics
Microbiology
Hematology
Coagulation/Hemostatis
Urinalysis
Other Technologies
(Other Technologies comprises of hybridization and loop-mediated isothermal amplification among others)
IVD Reagents Market, by Type

Antibodies
Antibodies Market, By Type
Monoclonal
Polyclonal
Antibodies Market, By Target
CD
TCR
EGFR
Other Targets
Oligonucleotides
Nucleic Acid Probes
Purified Proteins or Peptides
Other Reagents
(Other reagents include Blocking Agents, Detergents, Surfactants, Wetting Agents, Buffers, Stabilizers, Purified Water, Dyes, Standards & Controls, Enzymes, Cell Culture Reagents, and Anti-coagulants)
IVD Reagents Market, by Use

Research Use Only
Analyte Specific Reagents
Clinical Use
IVD Reagents Market, by End User

IVD Manufacturers
Reference Laboratories
Academic and Research Institutes
Hospital Laboratories
IVD Reagents Market, by Geography

North America
U.S.
Canada
Europe
Germany
Italy
France
U.K.
Spain
Rest of Europe (RoE)
Asia-Pacific (APAC)
Japan
China
India
Rest of Asia Pacific (RoAPAC)
Latin America
Middle East & Africa
๐‘ซ๐’๐’˜๐’๐’๐’๐’‚๐’… ๐‘บ๐’‚๐’Ž๐’‘๐’๐’† ๐‘น๐’†๐’‘๐’๐’“๐’• @https://www.meticulousresearch.com/download-sample-report/cp_id=5110?utm_source=prodyuct&utm_medium=Social&utm_campaign=Product&utm_content=15-12-2022
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By amey shinde
Phone 8563921741
Business Address In Vitro Diagnostic (IVD) Reagents Market Worth $77.6 Billion by 2027
In Vitro Diagnostic (IVD) Reagents Market Worth $77.6 Billion by 2027
Country India
Categories Health , Technology
Tags ivd , health , healthcare
Last Updated December 28, 2022